buflomedil has been researched along with Hypertrophy in 1 studies
buflomedil: RN given refers to parent cpd; synonym LL 1656 refers to HCl; structure
Hypertrophy: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Buflomedil was administered intraoperatively and for 14 days after the procedure." | 1.35 | The use of buflomedil in reduction mammaplasty for a previously irradiated breast: a case report. ( Pitanguy, I; Radwanski, HN; Sterodimas, A; Vargas, A, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sterodimas, A | 1 |
| Vargas, A | 1 |
| Radwanski, HN | 1 |
| Pitanguy, I | 1 |
1 other study available for buflomedil and Hypertrophy
| Article | Year |
|---|---|
The use of buflomedil in reduction mammaplasty for a previously irradiated breast: a case report.
Topics: Breast; Female; Humans; Hypertrophy; Mastectomy, Segmental; Middle Aged; Pyrrolidines; Vasodilator A | 2008 |